Pipemidic acid: absorption, distribution, and excretion
- PMID: 1147580
- PMCID: PMC429159
- DOI: 10.1128/AAC.7.4.441
Pipemidic acid: absorption, distribution, and excretion
Abstract
Pipemidic acid was absorbed well by the oral route. Its peak levels in plasma ranged from 4 to 12 mug/ml at an oral dose of about 50 mg/kg in mice, rats, dogs, monkeys, and men. The protein binding of pipemidic acid was about 20% in dog plasma and about 30% in human serum. Pipemidic acid was distributed to most of the organs and tissues tested at the concentrations comparable to or higher than the plasma level. Its concentrations in bile and urine were much higher than the plasma level. About 25 to 88% of orally administered pipemidic acid was excreted into urine in a bacteriologically active form, the percentage depending on the animals and doses employed. The remainder was excreted into feces in men. The main active principle in vivo was unchanged pipemidic acid itself. The mean lethal dose of pipemidic acid after a single oral dose was more than 16,000 mg/kg in mice. No abnormalities were observed in mice orally receiving pipemidic acid once a day for 4 weeks at doses of 1,000, 2,000, and 4,000 mg/kg per day, and in rats orally receiving the drug once a day for 2 weeks at doses of 400 and 1,600 mg/kg per day.
Similar articles
-
Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys.Antimicrob Agents Chemother. 1983 Jul;24(1):54-60. doi: 10.1128/AAC.24.1.54. Antimicrob Agents Chemother. 1983. PMID: 6226241 Free PMC article.
-
Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans.Antimicrob Agents Chemother. 1984 Apr;25(4):463-72. doi: 10.1128/AAC.25.4.463. Antimicrob Agents Chemother. 1984. PMID: 6587830 Free PMC article.
-
Pharmacokinetic studies of norfloxacin in laboratory animals.Chemotherapy. 1984;30(5):288-96. doi: 10.1159/000238283. Chemotherapy. 1984. PMID: 6237890
-
Absorption, distribution and excretion of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate in rats, dogs and monkeys.Arzneimittelforschung. 1986 Aug;36(8):1221-8. Arzneimittelforschung. 1986. PMID: 3778559
-
Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.Arzneimittelforschung. 2001 Sep;51(9):699-725. doi: 10.1055/s-0031-1300105. Arzneimittelforschung. 2001. PMID: 11642003 Review.
Cited by
-
Pipemidic acid, a new antibacterial agent active against Pseudomonas aeruginosa: in vitro properties.Antimicrob Agents Chemother. 1975 Aug;8(2):132-8. doi: 10.1128/AAC.8.2.132. Antimicrob Agents Chemother. 1975. PMID: 810076 Free PMC article.
-
Pipemidic acid: its activities against various experimental infections.Antimicrob Agents Chemother. 1976 Apr;9(4):569-74. doi: 10.1128/AAC.9.4.569. Antimicrob Agents Chemother. 1976. PMID: 1267435 Free PMC article.
-
New Pharmacokinetic and Microbiological Prediction Equations to Be Used as Models for the Search of Antibacterial Drugs.Pharmaceuticals (Basel). 2022 Jan 20;15(2):122. doi: 10.3390/ph15020122. Pharmaceuticals (Basel). 2022. PMID: 35215235 Free PMC article.
-
Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition.Eur J Clin Pharmacol. 1990;39(1):63-9. doi: 10.1007/BF02657060. Eur J Clin Pharmacol. 1990. PMID: 2177401
-
Comparative pharmacokinetic profiles of cinoxacin and pipemidic acid in humans.Eur J Drug Metab Pharmacokinet. 1983 Jul-Sep;8(3):251-9. doi: 10.1007/BF03188755. Eur J Drug Metab Pharmacokinet. 1983. PMID: 6653617
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources